EUDA Health Holdings Limited is a non-invasive and preventive healthcare company focused on longevity in Asia, with strategic presence in Singapore, Malaysia, and China. The group offers a portfolio spanning bioenergy-based treatments, stem cell therapy, and CRISPR gene editing, along with Helixé nutragenic supplements. Their mission centers on transforming regional healthcare from reactive treatment to proactive, longevity-focused care across Southeast Asia and China. They emphasize science-backed solutions designed to enhance immunity, vitality, and cellular recovery.
No recent news for this company.
No recent deals for this company.